CRISPR-Cas9 is a tool for gene editing that is faster and more precise than traditional options. (Image: iStock)

Evotec licenses CRISPR gene editing tech

By Melissa Fassbender

Evotec AG has entered into a non-exclusive license agreement with the MIT’s Broad Institute and Harvard for the use of CRISPR-Cas9 gene editing technology.